We are nearing a point of no return for GLP-1 drugs. More than one in 10 Americans have already taken a GLP-1 agonist, be it ...

Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

Q: I wish I could go to a doctor who could outline a personalized plan for improving and protecting my health, but that’s ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.